Discover the power of prenatal screening

Discover the power of prenatal screening on B·R·A·H·M·S  KRYPTOR analyzers


Get the full B·R·A·H·M·S Fast Screen PLUS software features overview  and see how streamlined workflows and powerful algorithms can enhance prenatal screening assessment workflows

Key features

More than just a risk assessment software, experience the difference with Thermo Scientific™ B·R·A·H·M·S Fast Screen™ PLUS software
 

Designed to support multiple prenatal screening strategies

Flexible and scalable solution for different clinical needs

Intuitive, user-friendly interface for efficient workflows

Secure, compliant platform for data protection


Experience the intuitive interface and unlock the full potential of our software

Worklist management

Track the status of your patients' records and quickly identify people at risk requiring prompt review

Intelligent interface

Make interaction more intuitive, enter information following suggestions or automation features to simplify tasks

Robust algorithms

Uses an engine based on a large FMF (Fetal Medicine Foundation) database to calculate risks in your population

Patient dashboard

Use a dedicated medical folder in which you can follow examinations, additional procedures and outcome of the pregnancies

One solution covering prenatal screenings and supporting pre-eclampsia management

An integrated solution supporting risk assessment and continuity of care throughout the pregnancy journey

1T Trisomy screening Up to 4 biomarkers *
2T Trisomy screening and NTD (Neural Tube Defect) Up to 4 biomarkers **
Double, triple, quadruple test
AFP for NTD
Pre-eclampsia screening in pregnancy 1st Trimester (PlGF, PAPP-A, PlGF+PAPP-A)
2nd Trimester (PlGF and sFlt-1)
3rd Trimester (PlGF and sFlt-1)
Pre-eclampsia management with ratio sFlt-1/PlGF in short-term prognosis and diagnosis 

* PAPP-A, Free βhCG, AFP, PlGF

** AFP, hCG/Free βhCG, uE3, Inhibin A

PAPP-A = Pregnancy-associated plasma protein A

Free βhCG = Free β human chorionic gonadotrophin 

PlGF = Placental growth factor 

sFlt-1 = Soluble fms-like tyrosine kinase 1 

AFP = Alpha fetoprotein 

hCG + β = Total human chorionic gonadotrophin

uE3 = Unconjugated estriol



Leadership Perspective

Confidence in care begins with confidence in results. At Thermo Fisher, our role is to support your clinical decision.”
— Christophe Fraudeau

 

Vice President & General Manager, Biomarkers

Watch the full internal interview to hear Christophe share the strategic vision behind B·R·A·H·M·S Fast Screen PLUS

Related products

B·R·A·H·M·S KRYPTOR Analyzers

Immunoanalyzers help provide precision testing to support prenatal screening workflows.

Scientific references

1. First-trimester combined screening for trisomy 21 at 7-14 weeks’ gestation

D. Wright et al., Ultrasound Obstet Gynecol, 2010

Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.

 

© 2026 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S and B·R·A·H·M·S Fast Screen are registered trademarks of B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific. is a registered trademark of B·R·A·H·M·S GmbH.

 

KRYPTOR is a trademark of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific.

Prenatal software: B·R·A·H·M·S Fast Screen pre I plus for pre-eclampsia screening

Discover our modern, powerful and robust clinical prenatal screening software for pre-eclampsia in first trimester.

 

Thermo Scientific B·R·A·H·M·S Fast Screen pre I plus is a CE marked prenatal screening software. This software, designed to be used with Thermo Scientific B·R·A·H·M·S KRYPTOR Instruments and Assays, ensures convenience of data entry, risk calculation and reporting for laboratories with both low and high data throughput. 

Key features


More than just a risk calculation tool for your pre-eclampsia screening

Simple and user-friendly interface available in six languages

Available in English, German, French, Spanish, Italian, and Turkish



References

  1. Concerning free βhCG and PAPP-A medians please refer to D. Wright et al., “First-trimester combined screening for trisomy 21 at 7-14 weeks’ gestation” Ultrasound Obstet. Gynecol., vol. 36, no. 4, pp. 404–411, 2010.
  2. Concerning PlGF medians please refer to P. Pandya et al., “Maternal serum placental growth factor in prospective screening for aneuploidies at 8-13 weeks’ gestation” Fetal Diagn. Ther., vol. 31, no. 2, pp. 87–93, 2012.
  3. N. O’Gorman et al., “Accuracy of competing risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation” Ultrasound Obstet. Gynecol., vol. 208, no. 2, pp. 109–112, Jan. 2017.

Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.

 

© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S is a registered trademark of B·R·A·H·M·S GmbH.

 

KRYPTOR and TRACE are trademarks of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific. Nobel Prize is a registered trademark of the Nobel Foundation.